) has further strengthened its endovascular portfolio. The
company, with the receipt of CE Mark approval for the Sentrant
Introducer Sheath, will be launching this product
internationally. Currently, MDT is demonstrating its
complete portfolio of stent grafts and related accessories at the
Charing Cross symposium in London.
According to the company, this new device will complement its
market-leading portfolio of stent grafts for the endovascular
repair of aortic aneurysms and related conditions, thereby
expanding Medtronic`s accessories toolkit for endovascular aortic
Specifically, the Sentrant Introducer Sheath will be used
together with Medtronic's Endurant II AAA and Valiant Captivia
Stent Graft Systems. It also complements other comparable devices
for endovascular repair. This new Sentrant Introducer Sheath will
be available in various sizes to adjust to different
Medtronic's Cardiac and Vascular segment, accounting for 53%
of revenues, offer minimally invasive products and therapies for
the treatment of atrial fibrillation, information systems for the
management of patients with CRDM devices, coronary and peripheral
stents and related delivery systems, therapies for uncontrolled
hypertension, endovascular stent graft systems, heart valve
replacement technologies, cardiac tissue ablation systems, and
open heart and coronary bypass grafting surgical products. We
believe that the successful commercialization of this
drug-eluting balloon in the U.S. will lead to revenue growth of
this segment going ahead.
We are encouraged by Medtronic's focus on portfolio expansion
along with its aim to boost revenues from the emerging markets.
Meanwhile, Medtronic continues to target return of 50% of the
free cash flow to shareholders. However, unfavorable currency and
macroeconomic uncertainty in Southern Europe adversely affected
sales. These headwinds have also adversely affected the company's
Medtronic retains a Zacks Rank #3 (Hold). Some of the Zacks
Rank #1 (Strong Buy) stocks are
Given Imaging Ltd.
BOSTON SCIENTIF (BSX): Free Stock Analysis
CYBERONICS INC (CYBX): Free Stock Analysis
GIVEN IMAGING (GIVN): Free Stock Analysis
MEDTRONIC (MDT): Free Stock Analysis Report
To read this article on Zacks.com click here.